Context: In vitro studies and anecdotal clinical reports have suggested that clinically significant rebound hypercoagulability may occur after discontinuation of oral anticoagulants (OACs), such ...

It may be postulated, however, that any blood protein or platelet defect associated with hypercoagulability and thrombosis could be associated with placental vascular thrombosis and recurrent ...